Login / Signup

Factors Associated With Adherence to First-line Antiviral Therapy Among Commercially Insured Patients With Chronic Hepatitis B.

Jonathan D AlpernHeesoo JooNathan C BahrThomas M Leventhal
Published in: Open forum infectious diseases (2023)
Ninety-day and mixed-duration supplies of entecavir and TDF were associated with higher fill rates as compared with 30-day supplies among commercially insured patients with CHB.
Keyphrases
  • hepatitis b virus
  • type diabetes
  • glycemic control
  • skeletal muscle
  • liver fibrosis
  • bone marrow
  • replacement therapy